Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 10, 2018

View Archived Issues

Phase II results on regorafenib in patients with metastatic osteosarcoma

ChlaDUB1, a Chlamydia effector protein with dual deubiquitination and acetylation activities

Hantavirus cell entry occurs by interaction between protocadherin-1 and viral surface glycoproteins

Mice, MRI and malaria

Claudin changes lead to leaky BBB after stroke

Antibody improves animal ALS symptoms

Patient dosing initiated in phase I study of BAT-4306F

Seres Therapeutics initiates phase II study of SER-287 in ulcerative colitis

FF-10501-01 demonstrates evidence of efficacy in patients with AML and MDS

PARP14 identified as a novel therapeutic target in STAT6-mutant follicular lymphoma

Calithera Biosciences presents early phase II results for CB-839 plus paclitaxel in advanced TNBC

Tychan initiates first-in-human study of TY-014 for Yellow fever

First clinical data presented for TK-006 in breast cancer patients with bone metastasis

E-2814 to begin phase I trials early next year for Alzheimer's disease

FDA places partial clinical hold on phase I studies of MGD-009

Bristol-Myers Squibb and Vedanta collaborate to study Opdivo with VE-800 in advanced cancers

Arctic Pharma discovers lactate dehydrogenase A inhibitors

Sigma1R ligands described by Integrative Research Laboratories Sweden

New P2X4 receptor antagonists synthesized at Bayer

Idorsia Pharmaceuticals patents prostanoid EP2 and/or EP4 receptor antagonists

Taizhou Huayuan Medicinal Tech describes deuterated anxiolytic compounds

C4X Discovery Holdings and e-therapeutics collaboration meets success

Phase I/II trial data of VAL-201 show dose-dependent response in PSA reduction

Avacta enters development alliance with LG Chem Life Sciences

Affimed outlines plans for clinical development and registrational plans for AFM-13

e-therapeutics enters type 2 diabetes research collaboration with Novo Nordisk

Researchers develop new murine model of neurodegeneration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...